J0890 Peginesatide injection
Also known as: Omontys, peginesatide
Peginesatide injection, an erythropoiesis-stimulating agent with extended half-life for treatment of anemia in end-stage renal disease patients.
In Plain Language
Long-acting medicine to increase red blood cells
Clinical Context
Used for treatment of anemia in patients with end-stage renal disease on hemodialysis with extended dosing intervals.
RVU Information
CPT J0890 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.
Billing & Documentation
J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.
Specialties
Frequently Asked Questions
What is CPT code J0890?
CPT J0890 (Peginesatide injection) is a J Codes (Drugs) code. Peginesatide injection, an erythropoiesis-stimulating agent with extended half-life for treatment of anemia in end-stage renal disease patients.
How is J0890 administered?
CPT J0890 is administered by a healthcare provider, typically via injection or infusion. Used for treatment of anemia in patients with end-stage renal disease on hemodialysis with extended dosing intervals. It is used by Nephrology, Dialysis, Internal Medicine.
When is CPT J0890 used?
Used for treatment of anemia in patients with end-stage renal disease on hemodialysis with extended dosing intervals.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.